ASX:FPHFisher & Paykel Healthcare Stock Price, Forecast & News

A$28.74

+0.74 (+2.64 %)

(As of 05/13/2020)

Add

Compare

Today's Range

A$27.82

Now: A$28.74▼

A$29.00

50-Day Range

A$25.30

MA: A$27.41▼

A$28.74

52-Week Range

A$14.00

Now: A$28.74▼

A$31.47

Volume575,466 shs

Average Volume371,449 shs

Market Capitalization$16.51 billion

P/E Ratio117.31

Dividend Yield0.86%

BetaN/A

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA). It operates through four segments: New Zealand, North America, Europe, and Asia-Pacific. The company offers adult respiratory products, such as AIRVO 2 system, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, including resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers surgical humidification systems; and homecare products comprising masks, CPAP devices, data management, humidifiers, and accessories. It markets and sells its products through its distribution subsidiaries, third party distributors, and original equipment manufacturers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Fisher & Paykel Healthcare.

2.1 Community Rank

Outperform Votes
Fisher & Paykel Healthcare has received 56 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Fisher & Paykel Healthcare has received 77 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Fisher & Paykel Healthcare has received 57.89% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Fisher & Paykel Healthcare and other stocks. Vote “Outperform” if you believe FPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Leadership
Fisher & Paykel Healthcare is a leading dividend payer. It pays a dividend yield of 0.86%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Fisher & Paykel Healthcare does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Fisher & Paykel Healthcare is 97.96 %. Payout ratios above 75% are not desirable because they may not be sustainable.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Fisher & Paykel Healthcare insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Earnings Growth
Earnings for Fisher & Paykel Healthcare are expected to decrease by -100.00% in the coming year, from A$0.35 to A$0.00 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Fisher & Paykel Healthcare is 117.31, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.56.
Price to Earnings Ratio vs. Sector
The P/E ratio of Fisher & Paykel Healthcare is 117.31, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.07.
Price to Book Value per Share Ratio
Fisher & Paykel Healthcare has a P/B Ratio of 30.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.75 out of 5 stars

Industry, Sector and Symbol

Stock Exchange ASX

Industry Medical Devices

Sub-IndustryN/A

SectorMedical

Current SymbolASX:FPH

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.fphcare.com

Phone+64-9-5740100

Debt

Debt-to-Equity Ratio14.55

Current Ratio2.06

Quick Ratio1.28

Price-To-Earnings

Trailing P/E Ratio117.31

Forward P/E Ratio80.99

P/E GrowthN/A

Sales & Book Value

Annual Sales$707.99 million

Price / Sales23.32

Cash FlowA$0.29 per share

Price / Cash Flow99.62

Book ValueA$0.93 per share

Price / Book30.90

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees4,000

Outstanding Shares574,574,976

Market Cap$16.51 billion

Next Earnings DateN/A

OptionableNot Optionable

Receive FPH News and Ratings via Email

Sign-up to receive the latest news and ratings for FPH and its competitors with MarketBeat's FREE daily newsletter.

Fisher & Paykel Healthcare (ASX:FPH) Frequently Asked Questions

How has Fisher & Paykel Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Fisher & Paykel Healthcare's stock was trading at A$24.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, FPH stock has increased by 19.2% and is now trading at A$28.74. View which stocks have been most impacted by Coronavirus.

How often does Fisher & Paykel Healthcare pay dividends? What is the dividend yield for Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare declared a interim dividend on Saturday, November 30th. Investors of record on Thursday, December 19th will be given a dividend of 0.114 per share on Thursday, December 19th. This represents a yield of 0.54%. The ex-dividend date is Friday, December 6th. This is a boost from Fisher & Paykel Healthcare's previous interim dividend of A$0.09. View Fisher & Paykel Healthcare's dividend history.

Has Fisher & Paykel Healthcare been receiving favorable news coverage?

News headlines about FPH stock have been trending negative on Monday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Fisher & Paykel Healthcare earned a daily sentiment score of -2.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutFisher & Paykel Healthcare.

Who are some of Fisher & Paykel Healthcare's key competitors?

Some companies that are related to Fisher & Paykel Healthcare include Cochlear (COH), ConvaTec Group (CTEC), Avita Medical (AVH), Stratec (SBS), Zynex (ZYXI), Draegerwerk AG & Co KGaA (DRW3), Avacta Group (AVCT), Creo Medical Group (CREO), Hamilton Thorne (HTL), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Medica Group (MGP), Electromed (ELMD), Electromed (ELMD), Cyclopharm (CYC) and Patient Home Monitoring (PTQ). View all competitors.

What other stocks do shareholders of Fisher & Paykel Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fisher & Paykel Healthcare investors own include ServiceNow (NOW), Allena Pharmaceuticals (ALNA), Broadcom (AVGO), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Okta (OKTA), Taiwan Semiconductor Mfg. (TSM), Altimmune (ALT), Ampliphi Biosciences (APHB) and Avid Technology (AVID).

Who are Fisher & Paykel Healthcare's key executives?

Fisher & Paykel Healthcare's management team includes the following people:

Mr. Lewis G. Gradon, MD, CEO & Exec. Director (Age 58)
Ms. Andrea Blackie, Acting Chief Financial Officer
Dr. Andrew Somervell, VP of Products & Technology
Rachel Reynolds, Sr. Communications Mang.
Mr. Paul N. Shearer, Sr. VP of Sales & Marketing

What is Fisher & Paykel Healthcare's stock symbol?

Fisher & Paykel Healthcare trades on the ASX under the ticker symbol "FPH."

What is Fisher & Paykel Healthcare's stock price today?

One share of FPH stock can currently be purchased for approximately A$28.74.

How big of a company is Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare has a market capitalization of $16.51 billion and generates $707.99 million in revenue each year. Fisher & Paykel Healthcare employs 4,000 workers across the globe.

What is Fisher & Paykel Healthcare's official website?

The official website for Fisher & Paykel Healthcare is www.fphcare.com.

How can I contact Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare's mailing address is 15 Maurice Paykel Place, East Tamaki, AUCKLAND, 1061, New Zealand. The company can be reached via phone at +64-9-5740100.

This page was last updated on 6/1/2020 by MarketBeat.com Staff